The 1964 masterpiece "Standard Station, Ten-Cent Western Being Torn in Half" could fetch $50 million or more in an upcoming ...

But these are not photographs: each hyperreal image is in fact a color pencil drawing, resulting from between 300 and 500 hours of careful construction. Now, Holmes’ works have been brought ...

The award-winning podcast JCO Cancer Stories: The Art of Oncology podcast unveils the hidden emotions ... Guest statements on the podcast do not express the opinions of ASCO. The mention of any ...

During the 1960s and '70s, Chicano artists mobilized to imagine liberation through a new identity and visual language.

Presidential Theme: The Art and Science of Cancer Care: From Comfort to Cure The ASCO Breakthrough abstracts on the ASCO 2023-2024 Presidential Theme of “The Art and Science of Cancer Care: From ...

Two impressive studies in lung cancer and another in breast cancer made Sunday a stellar day for AstraZeneca at the ASCO congress. Three of the group’s top cancer drugs were on display – EGFR ...

In June, at the American Society of Clinical Oncology (ASCO) conference in Chicago, when AstraZeneca discussed results from a phase 3 trial of its non-small cell lung cancer (NSCLC) blockbuster ...

The Hoodoo Mural Festival, now in its fifth year, brought art, music, and community together once again in downtown Amarillo.

She serves as the ASCO Applicant Pool Development Taskforce liaison to the ... Outgoing dean, Larry Davis, has positioned the school to provide state-of-the-art optometric education, engage in ...

The findings, presented at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on Sunday 2 June, involved analysing blood samples from the ChemoNEAR sample collection study for ...

Researchers hope these results, which are being presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, will lead to a new option for patients with advanced low-grade serous ...

Key oncology conferences like ASCO, ASH, and ESMO drive investment-informing ... Again, the patient numbers are too small to draw firm conclusions about the benefit of ivonescimab and/or ...